Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.76 |
| ▸ | MAPT | P10636 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.76 |
| ▸ | NPC1 | O15118 | 2/20 | 0.76 |
| ▸ | JUN | P05412 | 1/20 | 0.76 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.76 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.62 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.62 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.62 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | TNKS | O95271 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL334614 | 1.00 | RAB9A (0.76) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL334615 | 1.00 | RAB9A (0.76) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL29416684 | 1.00 | RAB9A (0.76) | RAB9AMAPTKDM4ENPC1JUN | |
| Hydrochloric Acid SCHEMBL27850886 | 0.98 | RAB9A (0.73) | RAB9AMAPTKDM4ENPC1JUN | |
| Hydrochloric Acid SCHEMBL10810828 | 0.98 | RAB9A (0.73) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL10898888 | 0.98 | RAB9A (0.73) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL8801611 | 0.87 | RAB9A (0.59) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL6642060 | 0.87 | RAB9A (0.59) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL6642064 | 0.87 | RAB9A (0.59) | RAB9AMAPTKDM4ENPC1JUN | |
| SCHEMBL5468278 | 0.87 | MAPT (0.64) | RAB9AMAPTKDM4ENPC1JUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2431502-B1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM & HAAS ELECT MAT (US) | 2017-05-24 | — | — | EP | claimed |
| US-8608932-B2 | Cyanide-free silver electroplating solutions | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-12-17 | — | — | US | claimed |
| US-20120067735-A1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-03-22 | — | — | US | claimed |
| EP-2431502-A2 | Cyanide-free silver electroplating solutions | Rohm and Haas Electronic Materials LLC (US) | 2012-03-21 | — | — | EP | claimed |
| US-20240217932-A1 | PYRIDIUM ESTERS | THE PROCTER AND GAMBLE COMPANY | 2024-07-04 | — | — | US | disclosed |
| EP-4374698-A1 | PYRIDINIUM ESTERS | The Procter & Gamble Company (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3704094-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Calico Life Sciences LLC (US) | 2020-09-09 | — | — | EP | disclosed |
| US-9994558-B2 | Multicyclic compounds and methods of using same | Karyopharm Therapeutics Inc. (US) | 2018-06-12 | — | — | US | disclosed |
| US-9994558-B2 | Multicyclic compounds and methods of using same | Karyopharm Therapeutics Inc. (US) | 2018-06-12 | — | — | US | disclosed |
| US-9994558-B2 | Multicyclic compounds and methods of using same | Karyopharm Therapeutics Inc. (US) | 2018-06-12 | — | — | US | disclosed |
| EP-2431502-B1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM & HAAS ELECT MAT (US) | 2017-05-24 | — | — | EP | disclosed |
| US-20170096417-A1 | Multicyclic Compounds And Methods Of Using Same | Karyopharm Therapeutics Inc. (US) | 2017-04-06 | — | — | US | disclosed |
| US-20170096417-A1 | Multicyclic Compounds And Methods Of Using Same | Karyopharm Therapeutics Inc. (US) | 2017-04-06 | — | — | US | disclosed |
| US-20170096417-A1 | Multicyclic Compounds And Methods Of Using Same | Karyopharm Therapeutics Inc. (US) | 2017-04-06 | — | — | US | disclosed |
| WO-2015042414-A1 | MULTICYCLIC COMPOUNDS AND METHODS OF USING SAME | Karyopharm Therapeutics Inc. (US) | 2015-03-26 | — | — | WO | disclosed |
| WO-2015042414-A1 | MULTICYCLIC COMPOUNDS AND METHODS OF USING SAME | Karyopharm Therapeutics Inc. (US) | 2015-03-26 | — | — | WO | disclosed |
| CN-103717574-A | Novel compounds and compositions for the inhibition of nampt | FORMA TM LLC | 2014-04-09 | — | — | CN | disclosed |
| US-8608932-B2 | Cyanide-free silver electroplating solutions | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-12-17 | — | — | US | disclosed |
| US-20120067735-A1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-03-22 | — | — | US | disclosed |
| EP-2431502-A2 | Cyanide-free silver electroplating solutions | Rohm and Haas Electronic Materials LLC (US) | 2012-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096417-A1 | Multicyclic Compounds And Methods Of Using Same | PAK4, PAK5, PAK1 | RAB9A 487/4885MAPT 1510/4885KDM4E 611/4885 |
| US-20240217932-A1 | PYRIDIUM ESTERS | C5, CBR3, CHRM1 | RAB9A 3949/4885MAPT 4762/4885KDM4E 1739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.